DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)
South Korea · Delayed Price · Currency is KRW 9,300.00
-690.00 (-6.91%)
At close: Jul 20, 2026
DAE HWA Pharmaceutical Market Cap
DAE HWA Pharmaceutical has a market cap or net worth of 162.9 billion as of July 20, 2026. Its market cap has decreased by -40.00% in one year.
Market Cap
162.90B
Enterprise Value
258.71B
Revenue
143.42B
Ranking
n/a
PE Ratio
90.40
Stock Price
9,300.00
ChartMarket Cap Chart
Since March 1, 2004, DAE HWA Pharmaceutical's market cap has increased from 15.67B to 162.90B, an increase of 939.72%. That is a compound annual growth rate of 11.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 162.90B | -46.64% |
| Dec 30, 2025 | 305.32B | 59.32% |
| Dec 30, 2024 | 191.63B | 16.63% |
| Dec 28, 2023 | 164.31B | -0.21% |
| Dec 29, 2022 | 164.66B | 0.86% |
| Dec 30, 2021 | 163.26B | -39.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HEM Pharma | 287.41B |
| ImmuneOncia Therapeutics | 275.19B |
| NOVAREX | 231.71B |
| CellBion | 170.48B |
| Cosmax Nbt | 160.94B |
| GC WellBeing | 145.27B |
| Vivozon Pharmaceutical | 145.00B |
| Kyung Dong Pharmaceutical | 134.44B |